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Purpose/Objective: Brachytherapy is the cornerstone of 
radiotherapy treatment in cervical cancer. In the last decade 
an increasing number of publications based on single 
institution large series indicate MR based IGABT as the new 
gold standard of treatment allowing a dramatic decrease of 
morbidity and at the same time an increase in local control 
especially for large tumors. Hereby we describe preliminary 
dosimetric results of MR IGABT at our institution. 
Materials and Methods: Since December 2012, 71 
consecutive patients (median age 50,5; range 31- 88,5) with 
a histologically proven diagnosis of locally advanced cervical 
cancer have been referred to GYN tumor board at our 
Institution.  
FIGO stage distribution was the following: 5 had Ib1, 4 had 
Ib2, 1 had IIA, 28 had IIB with mid proximal parametrial 
invasion, 12 had IIB with distal parametrial invasion, 1 had 
IIIA, 13 had IIIB (11 because pelvic wall invasion), 7 had IVA 
cancers. All cases were Diagnostic routine for all patients 
consisted in thorax and abdomen CT and pelvic MR. PET CT 
was obtained in selected cases. All patients had laparoscopic 
retroperitoneal lymphadenectomy. All patients received 
radio-chemotherapy consisting 3DCRT (45 Gy in 25 fr.) 
concomitant to chemotherapy (weekly cisplatin 40 mg m2) 
followed by 4 fraction of 7 Gy each within two different BT 
insertions. Median overall treatment time was 43 days. 2-3 
days before 1 BT implant all patients had a T2 MR scan to 
define tumor regression during radio-chemotherapy. All BT 
applications were performed under spinal anesthesia with 
TRUS and trans-abdominal US guidance. We used MR 
compatible Tandem Ovoids applicators (Elekta Utercht type) 
or Tandem Ring applicator (Elekta Vienna type) with either 
plastic or titanium needles if needed. At first application all 
patients had an MR with the applicator in place and a i.v. 
contrasted CT. A direct reconstruction approach based on 
applicator library or template was used to reconstruct 
applicators on MR images. Target volumes and OAR were 
contoured on MR according GEC ESTRO reccomendations. In 
all cases we started the planning process with a standard 
point A plan which was subsequently modified in order to 
reach our planning aims that are the following: HRCTV 
D9086Gy EQD2, Bladder D2cc<90 Gy EQD2, Rectum and 
Sigmoid bowel D2cc<70 GyEQD2. In the present study we 
report DVH comparison between Standard and optimized 
plans. 
Results: Preliminary dosimetric results are summarized in fig. 
1. At the present moment we had 2 patients with persistent 
disease after BT. Both cases were large IIIB tumors with 
infiltrative growth pattern and received a D90 dose of 85,21 
and 85,51 Gy EQD2 respectively. No intraoperative or 
perioperative events have been registered so far. 
Conclusions: In our preliminary experience MR based IGABT 
is strikingly superior to standard treatment. 
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Purpose/Objective: Image-Guided brachytherapy (IGBT) is 
related to treatment based on the 3D imaging for the 
planning procedure, not for the evaluation of the precision 
and accuracy of the treatment, which is the goal of the 
Image-Guided radiotherapy (IGRT). The aim of this study was 
assessment of probable intra-fractional organ displacement 
after the 3D imaging of the planning purpose.  
Materials and Methods: Thirty intracavitary bracytherapy 
insertions (with Rotterdam's tandem and ovoid applicators) of 
cervical cancer patients were studied. A CT scanning were 
done for each of the cases, for treatment planning, after the 
applicator insertion. Treatment planning was based on 
getting 80-90 Gy total dose to D90 of the HR-CTV (EQD2) and 
70Gy and 80Gy for rectum and bladder (D2cc), respectively. 
For each of those insertions a second CT scan were 
performed for the patients, just after the finishing of her 
treatment and before the applicators removed from her 
body. The scanning protocols (e.g. the amount of normal 
saline injection to the bladder Foley) were the same as the 
first CT imaging. Organ contouring and applicators 
reconstructions were performed with the same physician and 
physicist. The first 3D treatment planning were copied 
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manually (by dwell times and dwell positions insertion) to the 
second CTs. DVH parameters of OARs for two image series 
were compared and analyzed. It was tried to have a minimum 
time interval between the finishing of the treatment and 
second CT scanning. Paired samples T-test (Confidence 
Interval = 95%) was done for comparing the DVH parameters 
of two planning. 
Results: Mean(%)±SD of the absolute DVH parameters 
differences for bladder, rectum and sigmoid, as the OARs of 
cervical cancer patients are reported in the following table. 
 
 
Some example of the Paired samples T-test results in term of 
Mean±SD(P-value) are: -0.24±1.63 (0.428), 0.063±0.72(0.635) 
and -0.11±0.74(0.425) for D2cc of bladder, rectum and 
sigmoid, respectively.  
Although, results of the statistical analysis showed no 
meaningful variations between DVH parameters of before and 
after treatment CTs, but the absolute differences are not 
negligible, as it can be seen from the table.  
Conclusions: Despite the fact that statistical results were not 
significant, but, the differences were large and even 
sometimes re-planning may be needed, if pre-treatment CT 
images were available just before the source loading to the 
applicators.  
It can be concluded from the results that, the same as EBRT, 
also in the brachytherapy, on line imaging, just before, or 
even during, the source loading, provides a useful insight 
about the precision of the treatment. Conventional CT scan is 
not a best choice for online imaging, because of its high 
exposure, but the other modalities like ultrasound or C-arm 
can be used an alternative, if be available in the 
brachytherapy departments.  
 
 
 
 
 
Poster: Brachytherapy track: Head and neck  
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Purpose/Objective: Collecting data is expensive in terms of 
time and human resource. However data are collected 
differently and it is difficult to perform multi-center research 
based on previously stored data. The general objective of 
COBRA (COnsortium for BRachytherapy data Analysis) 
ontology is to define a specific data-set for SDC for H&N 
patients (pts) treated with brachytherapy (BT). 
Materials and Methods: ENT-COBRA is a consortium for SDC 
for H&N pts treated with BT. It is linked with H&N GEC-ESTRO 
Working Group (WG) and composed by 11 centers (10 
European and 1 Asian) from 6 countries. The ontology was 
defined by a multicenter WG, then, the proposal was 
evaluated by the consortium and by a multi-professional 
technical commission (TeCo) composed by a mathematician, 
an engineer, a doctor with experience in data storage, a 
programmer and a software (SW) expert. 
Results: 227 variables were defined. Each variable has 4 
properties: Name, Form, Type of Field and Levels. 13 Forms 
were proposed: 1) registry and history, 2) histology, 3) 
Staging, 4) Protocol, 5) Surgery, 6) Radiotherapy, 7) 
Neoadjuvant Chemotherapy (CT), 8) Concomitant CT, 9) 
Adjuvant CT, 10) BT, 11) Follow-up (repeated), 12) Outcome 
(automatically calculated based on F-up), 13) Images and 
Treatment files. Field types are: text, number, date, table, 
files. The chosen standard file formats are 'DICOM' for image 
and 'TXT files' for data treatment. All tables linked with 
variables are defined. The toxicity is stored with CTC4 scale 
and the RTOG scale (for back comparison with retrospective 
studies). RTOG scale was a forced choice because many data 
are stored using this and a direct mapping with CTC4 is not 
possible. There are 3 levels, each allowing for a specific type 
of analysis: 1) Registry level (epidemiology analysis), 2) 
Procedures level (standard oncology analysis), Research level 
(radiomics analysis). The variables of 'Registry level' are: pts 
code, Date of Birth, Gender, Ethnicity, Age, Site cancer, 
Multidisciplinary management, Institution, Histology type, 
therapy sequence, Death, Death Date, Cause of death. The 
third level includes image files. All other variables are in the 
'Procedures' level. The ontology was approved by the 
consortium and by the TeCo. The ontology has allowed to 
implement an automatic function (brokers) in COBRA SW, so 
it is not time-consuming because can take the data from 
common storage systems already in use in various centers. 
Possible update of the ontology repository are planned on 
regular bases among Consortium partners. 
Conclusions: The Ontology is a good answer to a multi-
dimensional problem that involves data collection, retrieval, 
and usability. This allows to create SW for large multi-centers 
database with the implementation of specific functions such 
as 'brokers'. The latter seem to be well received by all 
involved parties, primarily because it does not change the 
center storing technologies, procedures and habits.  
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